Group 1 - The core point of the article is that Shengda Bio (SH 603079) held its 24th meeting of the fourth board of directors on November 27, 2025, to discuss the election of non-independent directors for the fifth board [1] - Shengda Bio's revenue composition for the year 2024 is as follows: food additives account for 73.69%, feed additives for 18.55%, heating for 4.5%, other businesses for 3.17%, and miscellaneous for 0.1% [1] - As of the report date, Shengda Bio has a market capitalization of 3.5 billion yuan [1]

Investment Rating - The investment rating for the company is "Buy" and is maintained [6]. Core Views - The company reported a revenue of 3.814 billion yuan for Q3 2025, representing a year-on-year increase of 11.75% and a quarter-on-quarter increase of 7.73%. The net profit attributable to the parent company was 153 million yuan, up 51.53% year-on-year and 29.11% quarter-on-quarter. The non-recurring net profit was 139 million yuan, reflecting a year-on-year growth of 37.76% and a quarter-on-quarter growth of 38.07% [2][4]. Financial Performance - In Q3 2025, the company's electrolyte shipments are expected to maintain high growth, benefiting from a tight supply in the industry, leading to an increase in market share. The profitability of the electrolyte segment remained stable, with net profit per ton unchanged quarter-on-quarter. The price of 6F has accelerated its increase since October, which is expected to positively impact profitability in Q4 2025. The daily chemical business showed a growth trend, while resource recycling faced some losses due to resource price declines. The iron phosphate segment is anticipated to incur losses [12][12]. Future Outlook - The price of 6F is expected to continue rising, and the electrolyte segment is likely to benefit from this trend, leading to significant profit improvements in Q4 2025. For 2026, the company is expected to see further elasticity in 6F prices during a tight supply cycle, with significant increases in market share for electrolytes and LIFSI. The iron phosphate business is also projected to reach a supply-demand inflection point in 2026, potentially contributing to profit recovery. The solid-state battery business is progressing positively, with lithium sulfide samples expected to be sent out, and the company aims to enhance customer penetration and capacity reserves [12][12]. Earnings Forecast - The company is projected to achieve net profits attributable to the parent company of 1.2 billion yuan in 2025 and 5.1 billion yuan in 2026, corresponding to price-to-earnings ratios of 67 and 16 times, respectively [12].

Core Viewpoint - Wacker Chemie, a German chemical company, plans to cut over 1,500 jobs by 2027 as part of a cost savings program announced last month [1] Group 1 - The job cuts are part of a broader strategy to enhance operational efficiency and reduce costs [1] - The company aims to implement these changes by the year 2027 [1]

Core Viewpoint - Qing Shui Yuan's stock price increased by 4.74% with a trading volume of 1.425 billion yuan and a turnover rate of 41.08% on the day, indicating significant market activity and interest in the stock [2]. Trading Activity - The stock was listed on the Dragon and Tiger list due to its turnover rate reaching 41.08%, with institutional investors net selling 3.2819 million yuan [2]. - The top five trading departments on that day had a total transaction amount of 254 million yuan, with a buying amount of 120 million yuan and a selling amount of 134 million yuan, resulting in a net sell of 14.4107 million yuan [2]. - Among the trading departments, five institutional special seats were involved, with total buying amounting to 86.0623 million yuan and selling amounting to 89.3442 million yuan, leading to a net sell of 3.2819 million yuan [2]. Historical Performance - Over the past six months, the stock has appeared on the Dragon and Tiger list 11 times, with an average price increase of 5.47% the day after being listed and an average increase of 9.72% over the following five days [2]. Capital Flow - On the day of reporting, the stock experienced a net inflow of 1.3976 million yuan in main funds, with a significant single order net inflow of 10.2341 million yuan, while large orders saw a net outflow of 8.8365 million yuan [2]. - In the past five days, the net inflow of main funds totaled 24.3875 million yuan [2].

海科新源11月27日发布公告，公司股票连续三个交易日内日收盘价格涨幅偏离值累计超过30%，属于股 票交易异常波动的情况。经核实，公司前期披露的信息不存在需要更正、补充之处，公司经营情况及内 外部经营环境未发生或预计将要发生重大变化，公司、控股股东和实际控制人不存在关于本公司的应披 露而未披露的重大事项。 ...

Core Viewpoint - The POE film concept sector experienced a 1.99% increase, ranking fourth among concept sectors, with 21 stocks rising, including Mingguan New Materials and Saiwu Technology hitting the daily limit up [1] Group 1: Market Performance - The top gainers in the POE film concept include Mingguan New Materials with a 20% limit up, Saiwu Technology also hitting the limit up, and Haiyou New Materials, Dingjide, and Wanhua Chemical with increases of 4.24%, 3.78%, and 3.45% respectively [1] - The concept sectors with the highest and lowest daily changes include Organic Silicon at 3.29% increase and Hainan Free Trade Zone at a 2.65% decrease [1] Group 2: Capital Flow - The POE film concept sector saw a net inflow of 272 million yuan, with 14 stocks receiving net inflows, led by Wanhua Chemical with a net inflow of 153 million yuan [1] - The stocks with the highest net inflow ratios include Saiwu Technology at 28.94%, Mingguan New Materials at 26.80%, and Donghua Technology at 7.64% [2] Group 3: Stock Performance Details - Detailed stock performance shows Wanhua Chemical with a 3.45% increase and a turnover rate of 1.21%, while Saiwu Technology had a significant increase of 10.02% with a turnover rate of 8.29% [2][3] - Other notable performers include Haiyou New Materials with a 4.24% increase and a turnover rate of 3.10% [3]

Market Overview and Sector Characteristics - The Shanghai Composite Index rose by 0.29% with a decrease in trading volume, while the Shenzhen Component Index fell by 0.25% [2] - A total of 53 stocks hit the daily limit up, a decrease of 15 from the previous day, while 8 stocks hit the limit down, an increase of 5 [4] - The solid-state battery sector had the highest number of limit-up stocks today, indicating strong market interest [2] Sector Performance - The sectors with the most limit-up stocks included chemical products, consumer electronics, and photovoltaic equipment [5] - The chemical products sector saw 5 limit-up stocks due to rising chemical prices and recovering downstream demand [6] - The consumer electronics sector had 4 limit-up stocks driven by demand recovery and new product launches [6] - The photovoltaic equipment sector also had 4 limit-up stocks, supported by policy backing and growing export demand [6] Notable Stocks - Annie Co., Ltd. had the highest net inflow of funds among limit-up stocks, focusing on anti-counterfeiting traceability systems and paper products [2] - The stocks that reached a new high in the past year included Tongyu Communication, Guosheng Technology, and others, indicating significant market interest [7] - The top five stocks by net inflow of main funds included Furi Electronics, Annie Co., Ltd., and others, highlighting their attractiveness to investors [10] Fund Inflow and Market Sentiment - Annie Co., Ltd. had a net inflow of 393 million yuan, representing 7.54% of its market value, indicating strong investor interest [11] - The stocks with the highest net inflow of funds also included Huizhou Technology and Lian De Equipment, reflecting their popularity among investors [11] - The stocks with the most significant sealing funds included Xueqi Electric and Maoye Commercial, suggesting strong buying interest [12] Continuous Limit-Up Stocks - There were 43 stocks that hit the limit-up for the first time today, with 6 stocks achieving a second consecutive limit-up and 4 stocks achieving three or more consecutive limit-ups [13] - The stocks with the highest number of consecutive limit-ups included Jinfu Technology and Guangji Pharmaceutical, indicating strong market momentum [13]

Core Viewpoint - Jianlong Micro-Nano (688357.SH) announced the termination of its major asset restructuring plan, which involved acquiring at least 51% of Shanghai Hanxing Energy Technology Co., Ltd. The decision was made after discussions with all parties involved indicated that the conditions for the restructuring were not mature enough [1]. Group 1: Company Overview - Jianlong Micro-Nano was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 4, 2019, with an issuance of 14.46 million shares, accounting for 25.01% of the total share capital post-issuance, at a price of 43.28 yuan per share [2]. - The total amount raised from this issuance was 625.83 million yuan, with a net amount of 569.92 million yuan after expenses [2]. Group 2: Fundraising Activities - The total issuance costs for Jianlong Micro-Nano amounted to 55.91 million yuan, with underwriting and sponsorship fees of 46.17 million yuan [3]. - On April 4, 2023, the company announced the issuance of convertible bonds, raising a total of 700 million yuan, with a net amount of 690.05 million yuan after deducting issuance costs [4]. - The total amount raised from the three fundraising activities is calculated to be 1.52 billion yuan [5]. Group 3: Dividend Distribution - On June 2, 2023, Jianlong Micro-Nano announced a profit distribution plan based on a total share capital of 59,449,847 shares, distributing a cash dividend of 1.00 yuan per share and a capital reserve increase of 0.40 shares per share, resulting in a total cash dividend of 59.45 million yuan and an increase of 23.78 million shares [5]. - A subsequent profit distribution plan was announced for May 20, 2024, based on a total share capital of 83,381,988 shares, distributing a cash dividend of 0.60 yuan per share and a capital reserve increase of 0.20 shares per share, totaling 50.03 million yuan in cash dividends and an increase of 16.68 million shares [5].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][6][16] Core Views - The company has shown significant growth in revenue, achieving 440 million yuan in the first three quarters of 2025, a year-on-year increase of 17.59%. However, the net profit attributable to the parent company decreased by 20.41% to 58 million yuan [6] - The third quarter of 2025 saw a revenue of 169 million yuan, representing a year-on-year growth of 21.26%, with a net profit of 29 million yuan, up 15.8% year-on-year [6] - The report highlights the effective synergy from acquisitions and a steady recovery in downstream demand, leading to an upward revision of profit forecasts for 2025-2027 [6] - The expected net profits for 2025, 2026, and 2027 are projected to be 110 million, 160 million, and 200 million yuan respectively, with corresponding EPS of 0.33, 0.48, and 0.60 yuan [6] - The current stock price corresponds to P/E ratios of 38.8, 26.7, and 21.4 for the years 2025, 2026, and 2027 respectively [6] Financial Summary - The company plans to acquire 35% of Shanghai Youke for 61.25 million yuan, which is expected to enhance its product line in laboratory analysis instruments [7][8] - The financial projections indicate a steady increase in revenue from 403 million yuan in 2023 to 1.013 billion yuan in 2027, with a compound annual growth rate (CAGR) of 17.5% [9][11] - The net profit is expected to recover from 86 million yuan in 2023 to 212 million yuan in 2027, reflecting a significant growth trajectory [9][11] - The gross margin is projected to stabilize around 61.6% from 2025 onwards, while the net margin is expected to improve from 16.2% in 2025 to 19.7% in 2027 [9][11]

Core Viewpoint - Lianhua Technology's stock rose by 5.15% to 12.67 CNY per share, with a trading volume of 569 million CNY and a market capitalization of 11.401 billion CNY as of November 27 [1] Company Overview - Lianhua Technology Co., Ltd. is located in Taizhou, Zhejiang Province, established on September 14, 1998, and listed on June 19, 2008 [1] - The company operates in three main business segments: pesticides, pharmaceuticals, and functional chemicals [1] - Revenue composition: Pesticides 54.03%, Pharmaceuticals 32.32%, Functional Chemicals 8.42%, Equipment and Engineering Services 4.88%, Others 0.36% [1] Fund Holdings - One fund under China Merchants Fund holds a significant position in Lianhua Technology [2] - The fund, China Merchants CSI 2000 Index Enhanced A (019918), held 972,000 shares, accounting for 0.61% of the fund's net value, ranking as the eighth largest holding [2] - The fund has generated a floating profit of approximately 602,600 CNY today [2] Fund Performance - China Merchants CSI 2000 Index Enhanced A (019918) has a total asset size of 573 million CNY and has achieved a year-to-date return of 42.91%, ranking 619 out of 4206 in its category [2] - Over the past year, the fund has returned 43.35%, ranking 630 out of 4006 [2] - Since inception, the fund has delivered a return of 64.92% [2]